Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

336 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Exercise counselling and referral in cancer care: an international scoping survey of health care practitioners' knowledge, practices, barriers, and facilitators.
Ramsey I, Chan A, Charalambous A, Cheung YT, Darling HS, Eng L, Grech L, Hart NH, Kirk D, Mitchell SA, Poprawski D, Rammant E, Fitch MI, Chan RJ. Ramsey I, et al. Among authors: mitchell sa. Support Care Cancer. 2022 Nov;30(11):9379-9391. doi: 10.1007/s00520-022-07342-6. Epub 2022 Sep 29. Support Care Cancer. 2022. PMID: 36173560 Free PMC article.
Anakinra for refractory pustular psoriasis: A phase II, open-label, dose-escalation trial.
Naik HB, Pichard DC, Schwartz DM, O'Brien M, Masciocchi M, Thompson J, Sen HN, Steinberg SM, Mitchell SA, de Jesus AA, McCalmont TH, Dey A, Rosenstein RK, Deng Z, Goldbach-Mansky R, Mehta NN, Cowen EW. Naik HB, et al. Among authors: mitchell sa. J Am Acad Dermatol. 2022 Sep 16:S0190-9622(22)02694-9. doi: 10.1016/j.jaad.2022.07.065. Online ahead of print. J Am Acad Dermatol. 2022. PMID: 36116584 No abstract available.
Patient self-reporting of tolerability using PRO-CTCAE in a randomized double-blind, placebo-controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in patients with platinum resistant or refractory epithelial ovarian carcinoma.
Madariaga A, Mitchell SA, Pittman T, Wang L, Bowering V, Kavak N, Quintos J, Chang K, Ramsahai J, Karakasis K, Welch SA, Dhani NC, Lheureux S, Oza AM. Madariaga A, et al. Among authors: mitchell sa. Gynecol Oncol. 2022 Aug 30:S0090-8258(22)00544-3. doi: 10.1016/j.ygyno.2022.08.006. Online ahead of print. Gynecol Oncol. 2022. PMID: 36055813
336 results